Fund Manager Tries To Duck Valeant Insider Trading Claims

By Reenat Sinay (November 29, 2018, 9:40 PM EST) -- A hedge fund management company dug its heels into a renewed effort to ax a multibillion-dollar securities class action over Valeant Pharmaceuticals International Inc.'s massive 2016 stock drop, claiming in New Jersey federal court Wednesday that one of the investors failed to properly plead an insider trading allegation....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as